Cancer Treatment: NTX-1088 and Pembrolizumab

We are studying the effects of NTX-1088 alone and with Pembrolizumab in patients with cancer. The goal is to see if this combination improves treatment outcomes.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Narodowy Instytut Onkologii Im. Marii Sklodowskiej-Curie Panstwowy Instytut Badawczy
oddziat badan wczesnych faz
Ursynów, Poland
Sponsor: Nectin Therapeutics Ltd.
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.